vimarsana.com

ஆராய்ச்சி சபை பாப்யுலேஶந் ஆரோக்கியம் அலகு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

REGEN-COV™ (casirivimab and imdevimab) Phase 3 RECOVERY Trial Meets Primary Outcome, Improving Survival in Hospitalized COVID-19 Patients Lacking an Immune Response to SARS-CoV-2

REGEN-COV™ (casirivimab and imdevimab) Phase 3 RECOVERY Trial Meets Primary Outcome, Improving Survival in Hospitalized COVID-19 Patients Lacking an Immune Response to SARS-CoV-2
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Baby Aspirin As Effective As High-Dose for Heart

Baby Aspirin As Effective As High-Dose for Heart By Sue Hughes, Tricia Ward May 25, 2021 A new study found no difference in the rate of heart attack, stroke, or death between low- or high- dose aspirin in people with heart disease. There was also no difference in the rate of serious bleeding events that required a blood transfusion. This study involved more than 15,000 people who had heart disease. Half were told to take 81 mg of aspirin daily and half were told to take 325 mg. W. Schuyler Jones, MD, a cardiologist and associate professor of medicine at Duke University Medical Center in Durham, NC, presented the study results May 15 at the virtual American College of Cardiology 2021 Scientific Session. They were also published online in the 

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.